Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04757363
Title A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Regorafenib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.